Dosage adjustment during long-term adalimumab treatment for Crohn's disease: Clinical efficacy and pharmacoeconomics

William J. Sandborn, Jean Frédéric Colombel, Stefan Schreiber, Scott E. Plevy, Paul F. Pollack, Anne M. Robinson, Jingdong Chao, Parvez Mulani

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Fingerprint

Dive into the research topics of 'Dosage adjustment during long-term adalimumab treatment for Crohn's disease: Clinical efficacy and pharmacoeconomics'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science